Clinical Trials in Illinois

Showing 16341-16360 of 19,692 trials

Grass Observational Study

NCT02075138

Grass pollen allergens are universally recognised as a major cause of allergic diseases in humans, including asthma, allergic rhinitis, conjunctivitis and dermatitis. The purpose of the current study is to evaluate allergy symptoms and allergy medication in subjects with grass-related rhinoconjunctivitis.

Grass AllergyRhinoconjunctivitis

Circassia Limited109 participantsStarted Apr 2014

Washington D.C., District of Columbia, United States • Normal, Illinois, United States • Sylvania, Ohio, United States +4 more locations

COMPLETEDPhase 240 miles

Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome

NCT00879606

This is a prospective, randomized (1:1), double-blind, multi-center, Phase II clinical study to test the safety and efficacy of a recombinant chimeric anti-tissue factor antibody (ALT-836) versus placebo in patients with sepsis and acute lung injury/acute respiratory distress syndrome (ALI/ARDS). This study was divided into two parts and the first part of the study has been completed. In the first part of the study, sixty patients were randomized at a 1:1 ratio to receive one dose of the study drug or placebo. In the second part of the study, ninety patients will be randomized at a 1:1 ratio to receive a multi-dose treatment regimen of single doses every 72 hours up to a maximum of 4 doses of the study drug or placebo, provided there are no safety concerns.

SepsisAcute Lung InjuryAcute Respiratory Distress Syndrome

Altor BioScience150 participantsStarted Apr 2009

Los Angeles, California, United States • Sacramento, California, United States • Stanford, California, United States +17 more locations

Grass Observational Study

Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome

Find Trials by Condition in Illinois

Study Evaluating 13 Valent Pneumococcal Conjugate Vaccine With Trivalent Inactivated Influenza Vaccine

Study to Examine Safety, Tolerability, and Effect on Body Weight of Metreleptin Administered in Conjunction With Pramlintide in Obese and Overweight Subjects

Study of Denufosol (INS37217) in Subjects With Rhegmatogenous Retinal Detachment

Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults

Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index

CHARITE™ vs. ALIF 5-Year Follow-up

Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus

Study of GC1008 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

A Safety and Efficacy Study of DENSPM in Patients With Liver Cancer Who Are Not Eligible for Surgical Care

Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Safety Study Evaluating Intravenous Infusions of Tigecycline to Treat Acute Myeloid Leukemia

A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities)

Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin

Dose Escalation of IPI-493 in Hematologic Malignancies

Progressive Intervention Program for Tinnitus Management

Group Visits to Improve Hypertension Management

A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin